Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01922986 · ClinicalTrials.gov registry record · NA

Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT01922986: Completed NA study, sponsored by University of Minnesota.

NCT01922986 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01922986, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

When a certain area of the brain is injured, like in stroke, several events occur. One side of the body may become weak. This weakness is called hemiparesis and it may create difficulty in performing tasks like writing, eating, and walking. The weakness results from two sources: 1. death of some brain cells in the affected side (hemisphere) of the brain 2. exaggerated inhibitory signals from the unaffected hemisphere acting on surviving neurons in the affected hemisphere. Investigators cannot change neurons that have died but they may be able to change the exaggerated inhibition that impairs the surviving neurons in the affected hemisphere.The purpose of this study is to try to decrease the exaggerated inhibition coming from the unaffected hemisphere, which suppresses the affected hemisphere, with transcranial magnetic stimulation (TMS). Investigators hypothesize that, from admission to discharge, active rTMS combined with conventional therapy will produce greater functional gains in the paretic hand compared to sham rTMS combined with conventional therapy, as measured by standard tests.

Primary Outcome

This test quantifies the time it takes for the subject to do the following standardized functional tasks with the hand: stack three checkers, turn over cards, turn over empty cans, turn over fluid-filled cans, pick up and place small items like a paper clip, etc into a can, and use a spoon to scoop up a bean and drop the bean into a can. The unit of measure is time and changes that are negative signify reduced time at posttest compared to pretest, which would be an improvement. Total score = sum

Interventions

  • DEVICE sham rTMS
  • DEVICE active rTMS
  • BEHAVIORAL conventional stroke therapy

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2013-09
Est. Completion 2015-03
Phase NA
University of Minnesota

966 total trials

What the finished NCT01922986 record still lists

NCT01922986 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 3 interventions - of which sham rTMS is the first listed.

NCT01922986 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01922986 about?

NCT01922986 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke". When a certain area of the brain is injured, like in stroke, several events occur. One side of the body may become weak. This weakness is called hemiparesis and it may create difficulty in performing tasks like writing, eating, and walking. The weakness results from two sources: 1. death of some br...

What is the current status of trial NCT01922986?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2013-09. Estimated completion is 2015-03.

What interventions are being tested in trial NCT01922986?

The interventions under investigation include: sham rTMS (DEVICE), active rTMS (DEVICE), conventional stroke therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01922986?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01922986's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01922986, the US trial registry maintained by the National Library of Medicine. NCT01922986 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.